POTELIGEO
POTELIGEO
Approved
DIN Number
02527715
Drug Class
Human
Market Date
Mar 27, 2024
Company
HC
Kyowa Kirin, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02527715
AIG Number0163781001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FX09 MOGAMULIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MOGAMULIZUMABActive
Strength: 4 MG / ML
Monograph: MOGAMULIZUMAB